CL: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Million (M) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Net income including noncontrolling interests	2,266	1,499	726	2,270
Depreciation and amortization	457	299	148	457
Erisa litigation matter	65	65	65	0
Restructuring and termination benefits, net of cash	-15	-13	-7	54
Stock-based compensation expense	127	55	23	108
Deferred income taxes	8	-17	-24	-98
Receivables	180	152	174	184
Inventories	-9	-3	86	94
Accounts payable and other accruals	30	-248	-57	327
Other non-current assets and liabilities	22	7	14	2
Net cash provided by (used in) operations	2,745	1,484	600	2,838
Capital expenditures	387	232	124	377
Purchases of marketable securities and investments	537	384	134	358
Proceeds from sale of marketable securities and investments	508	350	97	260
Payment for acquisition, net of cash acquired	293	293	-	-
Other investing activities	5	1	-2	-21
Net cash provided by (used in) investing activities	-714	-560	-159	-454
Short-term borrowing (repayment) less than 90 days, net	139	-30	164	337
Principal payments of debt	655	139	4	502
Proceeds from issuance of debt	497	497	0	2
Dividends paid	1,300	880	406	1,275
Purchases of treasury shares	804	516	284	1,284
Proceeds from exercise of stock options	83	65	40	611
Other financing activities	145	136	32	1
Net cash provided by (used in) financing activities	-1,895	-867	-458	-2,110
Effect of exchange rate changes on cash and cash equivalents	47	62	33	-6
Net increase (decrease) in cash and cash equivalents	183	119	16	268
Cash and cash equivalents at beginning of period	1,096	1,096	1,096	966
Cash and cash equivalents at end of period	1,279	1,215	1,112	1,234

Unit: Million (M) dollars (except for numbers of shares and EPS)

CL: the cashflow